Stacy Ardoin

Stacy Ardoin, MD

  • Rheumatology

Appointments: (614) 293-4837

About Me

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2015, 2016, 2017
  • Named to the Castle Connolly list of America’s “Top Doctors” for 2017

Specialties and conditions I treat

  • Rheumatology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Aortitis
  • Arteritis
  • Arthritis, Juvenile Rheumatoid
  • Behcet Syndrome
  • Churg-Strauss Syndrome
  • Cogan Syndrome
  • Giant Cell Arteritis
  • Lupus Erythematosus, Cutaneous
  • Lupus Erythematosus, Discoid
  • Lupus Erythematosus, Systemic
  • Lupus Nephritis
  • Lupus Vasculitis, Central Nervous System
  • Microscopic Polyangiitis
  • Mixed Connective Tissue Disease
  • Panniculitis, Lupus Erythematosus
  • Polyarteritis Nodosa
  • Retinal Vasculitis
  • Rheumatoid Vasculitis
  • Systemic Vasculitis
  • Takayasu Arteritis
  • Vasculitis
  • Vasculitis, Central Nervous System
  • Vasculitis, Leukocytoclastic, Cutaneous
  • Wegener Granulomatosis
  • Rheumatology

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

Education and training

Medical Degree

MD
Ohio State University College of Medicine
6/13/1997

Residency

IM/Pediatrics
Ohio State University Wexner Medical Center
7/1/1997 - 6/30/2001

More about my work

My background

Fellowship

Rheumatology
Duke University Medical Center
7/1/2002 - 6/30/2006

Board Certifications

American Board of Internal Medicine
8/21/2001

American Board of Internal Medicine (Subspecialty: Rheumatology)
11/20/2006

American Board of Pediatrics
10/16/2001

American Board of Pediatrics (Subspecialty: Rheumatology)
11/16/2006

My Department

Internal Medicine

My Division

Rheumatology - Immunology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/2017, Dr. Ardoin has reported no financial relationships with medical device, research and/or drug companies.